Search Results

The Starswab Multitrans Collection and Transport System (Cat. No. S160) is intended for the collection and transportation of Chlamydia, Mycoplasmas and viruses obtained from clinical specimens.

Starswab Multitrans Collection and Transport System provides a safe and convenient way to collect and transport clinical specimens without leakage under optimum storage conditions. The osmotically balanced buffered medium will maintain the viability of viral, chlamydia and mycoplasma specimens during transportation to the laboratory. Antibiotics are incorporated into the medium to inhibit growth of competing bacteria and yeast. The addition of serum albumin provides a stabilizing effect. The high concentration of sucrose aids in the preservation of viruses and chlamydia if the specimens are frozen (-70℃) for prolonged storage.

"STARTOX" Drugs of Abuse Screening Test is a one-step lateral flow immunoassay intended for the simultaneous detection of multiple drug analytes in urine. "STARTOX" is intended for use in the qualitative detection of drugs of abuse at the following Substance Abuse Mental Health Services Administration (SAMHSA) recommended levels: | Compound | Abbreviation | Level | |---------------------------------------------------|--------------|------------| | Methamphetamine ((+/-)methamphetamine HCl) | METH | 1000 ng/ml | | Opiates (morphine) | OPI | 300 ng/ml | | Cocaine (benzoylecgonine) | COC | 300 ng/ml | | Cannabinoids<br>(11-nor-Δ9-THC-9-carboxylic-acid) | THC | 50 ng/ml | STARTOX™ Drugs of Abuse Screening Test provide only a preliminary qualitative test result. Use a more specific alternate quantitative analytical method to obtain a confirmed analytical result. Gas chromatography/mass spectrometry (GC/MS) is the preferred confirmatory method. Apply clinical and professional judgment to any drug of abuse test result, particularly when preliminary positive results are obtained. For professional use only.

A lateral flow immunoassay for the detection of drugs of abuse.

STARTOX™ Drugs of Abuse Screening Test is a one-step lateral flow immunoassay intended for the simultaneous detection of multiple drug analytes in urine. STARTOX™ is intended for use in the qualitative detection of drugs of abuse at the following Substance Abuse Mental Health Services Administration (SAMHSA) recommended levels: | Compound | Abbreviation | Level | |---------------------------------------------------|--------------|------------| | Amphetamine (d-amphetamine sulfate) | AMP | 1000 ng/ml | | Opiates (morphine-3-P-D glucuronide) | OPIATES | 2000 ng/ml | | Phencyclidine (phencyclidine HCl) | PCP | 25 ng/ml | | Cocaine (benzoylecgonine) | COCAINE | 300 ng/ml | | Cannabinoids<br>(11-nor-Δ9-THC-9-carboxylic-acid) | THC | 50 ng/ml | STARTOX™ Drugs of Abuse Screening Test provide only a preliminary qualitative test result. Use a more specific alternate quantitative analytical method to obtain a confirmed analytical result. Gas chromatography/mass spectrometry (GC/MS) is the preferred confirmatory method. Apply clinical and professional judgment to any drug of abuse test result, particularly when preliminary positive results are obtained. For professional use only.

A lateral flow immunoassay for the detection of drugs of abuse.

Not Found

The Starswab Culture Collection and Transport System is selfcontained, sterile and intended for maintaining the viability of clinical specimens during transportation to the laboratory. The medium contains sodium thioglycollate as a reducing agent and the moisture and media depth provide an ideal environment for the survival of both aerobic and anaerobic microorganisms.